Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : FlowVax COVID-19 Vaccine
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Undisclosed
Sponsor : Flow Pharma
Deal Size : Undisclosed
Deal Type : Partnership
Details : Oakwood will operate Flow Pharma's production volume vaccine manufacturing system , using Oakwood's state-of-the-art microsphere-based processing, quality testing, and packaging systems to make GMP FlowVax COVID-19 vaccine doses for clinical testing.
Product Name : Undisclosed
Product Type : Vaccine
Upfront Cash : Undisclosed
April 15, 2020
Lead Product(s) : FlowVax COVID-19 Vaccine
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Undisclosed
Sponsor : Flow Pharma
Deal Size : Undisclosed
Deal Type : Partnership